Table 2.
Stromelysin-1 (MMP-3) levels in relation to the occurrence of clinical endpoints.
| Endpoint | MMP-3 (pg/ml) median [range] | ||
|---|---|---|---|
| Event | No event | p-value | |
| Death/heart failure (N=58) | 9141.2 | 6230.2 | 0.001 |
| Death (N=33) | 9076.0 | 6550.1 | 0.033 |
| Heart failure (N=46) | 8068.0 | 6505.8 | 0.033 |
| Reinfarction (N=42) | 6941.6 | 6630.8 | 0.923 |